Skip to main content
SteadySharesSteadySharesSteadyStShares
The market
MarketsDiscover
Follow the money
Super InvestorsPolitician TradesCrypto Desk
Yours
My WealthNews
Settings Sign in to save your work
Open
SteadySharesMarketsDiscoverSuper InvestorsMy WealthPoliticiansCryptoNews
DiscoverSTXS
HealthcareASEUSD

Stereotaxis, Inc.

$00123456789.0012345678900123456789+3.3%
52w low (est.) $1.03$1.71 52w high (est.)
Market data · updated 1h ago
Market data
Market cap
USD149.44M
52w range
USD1.28 - USD3.59
Beta
1.34
Sector
Healthcare
Data quality
83/100
Valuation
DCF fair value
USD0.60
Margin of safety
-55.0%
PEG ratio
1.31
Quality & efficiency
Moat score
32/100
Return on equity
-156.1%
Profit margin
-69.5%
Debt / equity
0.27
Growth & analysts
Revenue growth
-15.8%
Analyst target
USD4.13
Target upside
+209.7%
Analysts
4
Run the 10-point checklist before you buy How these numbers are made

About Stereotaxis, Inc.

Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. The company offers robotic magnetic navigation (RMN) systems, such as Genesis RMN, which enable physicians to complete complex interventional procedures by providing image-guided delivery of catheters through the blood vessels and chambers of the heart to treatment sites; and GenesisX RMN System, which is designed to enhance the accessibility of Robotic Magnetic Navigation by reducing the lengthy construction cycle necessary to install prior generation RMN systems. It also offers Odyssey, a Synchrony and SynX Solution offer integrated, real-time information solution to manage, control, record and share procedures across networks; and x-ray systems. In addition, the company offers disposables and other accessories, including MAGiC catheter, a robotically navigated magnetic ablation catheter designed to perform minimally invasive cardiac ablation procedures; MAGiC Sweep, a mapping catheter; QuikCAS, an automated catheter advancement single-use disposable device; iCONNECT; and V-CAS devices. Further, it provides interventional devices under the Map-iT, MAGiC, and EMAGIN brands, and other related devices. It markets its products through direct sales force, distributors, and sales agents. Stereotaxis, Inc. was incorporated in 1990 and is based in Saint Louis, Missouri.

Valuation

ValueGrowthProfitHealthIncome21QUALITY
Overall Rating
21
Sell
Sell

Derived from filed metrics · High confidence (83% of the inputs available)

Moat Score32
DCF Intrinsic Value
USD0.60-55.0% downside

Moat, DCF and rating computed by our valuation engine (ported from the original Python model).

Fundamentals

Market Cap
USD149.44M
P/E Ratio
N/A
Dividend Yield
0.00%
Revenue Growth
-15.8%
Profit Margin
-69.5%
ROE
-156.1%
Debt / Equity
0.27
Beta
1.34
Beaten Down
vs Healthcare sector:Moat 32 vs 7Yield 0.00% vs 0.3%

Statistics

Similar Stocks · Healthcare

LLY73
$920.00+0.7%
AZN.L72
£105.20+0.6%
UNH71
$492.10+1.6%
JNJ70
$146.20-0.2%

Latest News · STXS